These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 30240176)

  • 1. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
    Hu W; Xin Y; He Z; Zhao Y
    Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
    Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
    Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.
    Zhang L; Zhang Y; Li R; Zhu J; Lin A; Yan Y; Zhang Z; Wang N; Xu G; Fu Y
    J Neurol; 2024 Aug; 271(8):4991-5002. PubMed ID: 38771386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
    Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
    Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies in Chronic Inflammatory Demyelinating Polyneuropathy].
    Koga M
    Brain Nerve; 2018 Apr; 70(4):395-403. PubMed ID: 29632287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody profile in a Malaysian cohort of chronic inflammatory demyelinating polyneuropathy.
    Tan CY; Goh KJ; Oh AW; Devaux J; Shahrizaila N
    Neuromuscul Disord; 2022 Mar; 32(3):255-262. PubMed ID: 35183410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody.
    Ogata H; Zhang X; Yamasaki R; Fujii T; Machida A; Morimoto N; Kaida K; Masuda T; Ando Y; Kuwahara M; Kusunoki S; Nakamura Y; Matsushita T; Isobe N; Kira JI
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2304-2316. PubMed ID: 31657126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.
    Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S
    Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
    Martinez-Martinez L; Lleixà MC; Boera-Carnicero G; Cortese A; Devaux J; Siles A; Rajabally Y; Martinez-Piñeiro A; Carvajal A; Pardo J; Delmont E; Attarian S; Diaz-Manera J; Callegari I; Marchioni E; Franciotta D; Benedetti L; Lauria G; de la Calle Martin O; Juárez C; Illa I; Querol L
    J Neuroinflammation; 2017 Nov; 14(1):224. PubMed ID: 29145880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
    Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
    Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
    J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
    Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
    J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review and Meta-Analysis of Autoantibodies for Diagnosis and Prognosis in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Guo X; Tang L; Huang Q; Tang X
    Front Neurosci; 2021; 15():637336. PubMed ID: 34108854
    [No Abstract]   [Full Text] [Related]  

  • 14. A case with Neurofascin-155 IgG antibody-associated combined central and peripheral demyelination: Successfully treated with anti-CD20 monoclonal antibody.
    Sokmen O; Demirci M; Tan E
    Clin Neurol Neurosurg; 2021 Nov; 210():106961. PubMed ID: 34624826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies.
    Zhang J; Hou X; Wei L; Liu J; Li S; Guo Y; Liu H; Jiang Y
    Front Immunol; 2024; 15():1345953. PubMed ID: 38726012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
    Kira JI
    Front Neurol; 2021; 12():665136. PubMed ID: 34177770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
    Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
    Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.
    Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC
    Muscle Nerve; 2018 May; 57(5):848-851. PubMed ID: 29130507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
    Kadoya M; Kaida K; Koike H; Takazaki H; Ogata H; Moriguchi K; Shimizu J; Nagata E; Takizawa S; Chiba A; Yamasaki R; Kira JI; Sobue G; Ikewaki K
    J Neuroimmunol; 2016 Dec; 301():16-22. PubMed ID: 27852440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.